Cardiovascular and renal properties of potassium-sparing diuretics of the spirolactone group--I: Effects of SC-14266/371 (potassium canrenoate) on renal transport Na+, K+-ATPase activity.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002191:Canrenoic Acid / Q000494:pharmacology*; D004232:Diuretics / Q000494:pharmacology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D007668:Kidney / Q000187:drug effects* / Q000201:enzymology; D007700:Kinetics; D008297:Male; D011245:Pregnadienes / Q000494:pharmacology*; D051381:Rats; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*
D004232:Diuretics; D011245:Pregnadienes; D002191:Canrenoic Acid; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D000254:Sodium-Potassium-Exchanging ATPase